Cullinan Therapeutics (CGEM) Change in Acquisitions & Divestments (2020 - 2023)
Historic Change in Acquisitions & Divestments for Cullinan Therapeutics (CGEM) over the last 4 years, with Q4 2023 value amounting to $117.5 million.
- Cullinan Therapeutics' Change in Acquisitions & Divestments fell 1140.12% to $117.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $409.4 million, marking a year-over-year increase of 1599.85%. This contributed to the annual value of $584.8 million for FY2024, which is 4284.84% up from last year.
- Latest data reveals that Cullinan Therapeutics reported Change in Acquisitions & Divestments of $117.5 million as of Q4 2023, which was down 1140.12% from $93.8 million recorded in Q3 2023.
- In the past 5 years, Cullinan Therapeutics' Change in Acquisitions & Divestments ranged from a high of $132.6 million in Q4 2022 and a low of $4.2 million during Q1 2020
- Moreover, its 4-year median value for Change in Acquisitions & Divestments was $61.4 million (2021), whereas its average is $63.6 million.
- As far as peak fluctuations go, Cullinan Therapeutics' Change in Acquisitions & Divestments skyrocketed by 66207.53% in 2022, and later crashed by 1140.12% in 2023.
- Cullinan Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $32.9 million in 2020, then skyrocketed by 86.41% to $61.4 million in 2021, then surged by 115.96% to $132.6 million in 2022, then decreased by 11.4% to $117.5 million in 2023.
- Its Change in Acquisitions & Divestments stands at $117.5 million for Q4 2023, versus $93.8 million for Q3 2023 and $93.6 million for Q2 2023.